USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
08 Dec 2022 | 03:45 PM GMT
Past Meeting

Driving Adoption for non-Prescription DTx

Anchored by:

NO LONGER HERE David Matthews
Chief Growth Officer
BRIGHTINSIGHT, INC.

Participants:

NO LONGER HERE David Matthews Chief Growth OfficerBrightInsight, Inc.Other
Other
NO LONGER HERE David Matthews
Chief Growth OfficerBrightInsight, Inc.
Chandana Fitzgerald President, CommunityHLTHOther
Other
Chandana Fitzgerald
President, CommunityHLTH
Ashley Pippin DirectorNovartis
Ashley Pippin
DirectorNovartis
Elisabeth Tsechanski Digital Innovation HubDaiichi Sankyo EuropeLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Elisabeth Tsechanski
Digital Innovation HubDaiichi Sankyo Europe
Jeff Wandzura CEOKEEP LabsStartup
Startup
Jeff Wandzura
CEOKEEP Labs
Jock Thompson CEOHyduro, Inc.Other
Other
Jock Thompson
CEOHyduro, Inc.
Malin Johansson Head of Life ScienceSleep CycleHealth Tech & Solutions
Health Tech & Solutions
Malin Johansson
Head of Life ScienceSleep Cycle
Mark Duman Managing Partner/Chief Patient OfficerMD Healthcare ConsultantsProfessional Services
Professional Services
Mark Duman
Managing Partner/Chief Patient OfficerMD Healthcare Consultants
Nita Thingalaya NA Medical Innovation LeadSanofiOther
Other
Nita Thingalaya
NA Medical Innovation LeadSanofi
Rick Bartels President/Founder DTxCCHealth Tech & Solutions
Health Tech & Solutions
Rick Bartels
President/Founder DTxCC

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations. 

 Without adoption, even the best DTx solution will have no impact. As healthcare evolves to a more patient-centric model, DTx products need to be more and more engaging to thrive in this competitive industry. This becomes especially important for non-prescription DTx products, where HCPs are not as actively involved in pushing patient activation and long-term engagement as in prescription DTx.  

Join us in a peer-to-peer conversation where we will discuss: 

  • Effective strategies to involve the patient from early on and leverage patient associations  
  • Patient awareness and activation strategies: what D2C marketing strategies have been successful? 
  • Leverage HCPs recommendations to drive patient adoption in non-prescription DTx 
  • Patient onboarding for non-prescription DTx products: is it the physician job, pharmacists, nurses, patients, or the DTx's customer service?  
  • Long-term patient retention: how to convert patients from acute therapy to maintenance? In behavioral change-based DTx, what are the KPIs for long-term engagement? 
  • Personalization vs. Scaling: is personalization possible when scaling?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville, TN | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.

© 2026 HLTH, INC. by Hyve Group - All Rights Reserved

About usPrivacy Policy Contact us